Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabo...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Teresa Arrobas Velilla [verfasserIn] Carlos Guijarro [verfasserIn] Raquel Campuzano Ruiz [verfasserIn] Manuel Rodríguez Piñero [verfasserIn] José Francisco Valderrama Marcos [verfasserIn] Antonio M. Botana López [verfasserIn] Ana Morais López [verfasserIn] José Antonio García Donaire [verfasserIn] Juan Carlos Obaya [verfasserIn] Luis Castilla Guerra [verfasserIn] Vicente Pallares Carratalá [verfasserIn] Isabel Egocheaga Cabello [verfasserIn] Mercedes Salgueira Lazo [verfasserIn] María Mar Castellanos Rodrigo [verfasserIn] José María Mostaza Prieto [verfasserIn] Juan José Gómez Doblas [verfasserIn] Antonio Buño Soto [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2023

Schlagwörter:	Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos

Übergeordnetes Werk:	In: Nefrología (English Edition) - Elsevier, 2017, 43(2023), 4, Seite 474-483
Übergeordnetes Werk:	volume:43 ; year:2023 ; number:4 ; pages:474-483

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.1016/j.nefroe.2023.08.002

Katalog-ID:	DOAJ099607034

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ099607034
003	DE-627
005	20240414043019.0
007	cr uuu---uuuuu
008	240414s2023 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.nefroe.2023.08.002 \|2 doi
035			\|a (DE-627)DOAJ099607034
035			\|a (DE-599)DOAJafe49b06e4354350a99f002b8f179c41
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC870-923
100	0		\|a Teresa Arrobas Velilla \|e verfasserin \|4 aut
245	1	0	\|a Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.
650		4	\|a Apolipoproteína B
650		4	\|a Bioquímica
650		4	\|a Colesterol
650		4	\|a Consenso
650		4	\|a Enfermedades cardiovasculares
650		4	\|a Lípidos
653		0	\|a Diseases of the genitourinary system. Urology
700	0		\|a Carlos Guijarro \|e verfasserin \|4 aut
700	0		\|a Raquel Campuzano Ruiz \|e verfasserin \|4 aut
700	0		\|a Manuel Rodríguez Piñero \|e verfasserin \|4 aut
700	0		\|a José Francisco Valderrama Marcos \|e verfasserin \|4 aut
700	0		\|a Antonio M. Botana López \|e verfasserin \|4 aut
700	0		\|a Ana Morais López \|e verfasserin \|4 aut
700	0		\|a José Antonio García Donaire \|e verfasserin \|4 aut
700	0		\|a Juan Carlos Obaya \|e verfasserin \|4 aut
700	0		\|a Luis Castilla Guerra \|e verfasserin \|4 aut
700	0		\|a Vicente Pallares Carratalá \|e verfasserin \|4 aut
700	0		\|a Isabel Egocheaga Cabello \|e verfasserin \|4 aut
700	0		\|a Mercedes Salgueira Lazo \|e verfasserin \|4 aut
700	0		\|a María Mar Castellanos Rodrigo \|e verfasserin \|4 aut
700	0		\|a José María Mostaza Prieto \|e verfasserin \|4 aut
700	0		\|a Juan José Gómez Doblas \|e verfasserin \|4 aut
700	0		\|a Antonio Buño Soto \|e verfasserin \|4 aut
773	0	8	\|i In \|t Nefrología (English Edition) \|d Elsevier, 2017 \|g 43(2023), 4, Seite 474-483 \|w (DE-627)837956323 \|w (DE-600)2837917-2 \|x 20132514 \|7 nnns
773	1	8	\|g volume:43 \|g year:2023 \|g number:4 \|g pages:474-483
856	4	0	\|u https://doi.org/10.1016/j.nefroe.2023.08.002 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 \|z kostenfrei
856	4	0	\|u http://www.sciencedirect.com/science/article/pii/S2013251423001335 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2013-2514 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 43 \|j 2023 \|e 4 \|h 474-483

Indexfelder

author_variant	t a v tav c g cg r c r rcr m r p mrp j f v m jfvm a m b l ambl a m l aml j a g d jagd j c o jco l c g lcg v p c vpc i e c iec m s l msl m m c r mmcr j m m p jmmp j j g d jjgd a b s abs
matchkey_str	article:20132514:2023----::osnudcmnfriipoieeemntoadeotnisaihlnclaoaoishtaaeesh
hierarchy_sort_str	2023
callnumber-subject-code	RC
publishDate	2023
allfields	10.1016/j.nefroe.2023.08.002 doi (DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41 DE-627 ger DE-627 rakwb eng RC870-923 Teresa Arrobas Velilla verfasserin aut Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio. Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology Carlos Guijarro verfasserin aut Raquel Campuzano Ruiz verfasserin aut Manuel Rodríguez Piñero verfasserin aut José Francisco Valderrama Marcos verfasserin aut Antonio M. Botana López verfasserin aut Ana Morais López verfasserin aut José Antonio García Donaire verfasserin aut Juan Carlos Obaya verfasserin aut Luis Castilla Guerra verfasserin aut Vicente Pallares Carratalá verfasserin aut Isabel Egocheaga Cabello verfasserin aut Mercedes Salgueira Lazo verfasserin aut María Mar Castellanos Rodrigo verfasserin aut José María Mostaza Prieto verfasserin aut Juan José Gómez Doblas verfasserin aut Antonio Buño Soto verfasserin aut In Nefrología (English Edition) Elsevier, 2017 43(2023), 4, Seite 474-483 (DE-627)837956323 (DE-600)2837917-2 20132514 nnns volume:43 year:2023 number:4 pages:474-483 https://doi.org/10.1016/j.nefroe.2023.08.002 kostenfrei https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 kostenfrei http://www.sciencedirect.com/science/article/pii/S2013251423001335 kostenfrei https://doaj.org/toc/2013-2514 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 43 2023 4 474-483
spelling	10.1016/j.nefroe.2023.08.002 doi (DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41 DE-627 ger DE-627 rakwb eng RC870-923 Teresa Arrobas Velilla verfasserin aut Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio. Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology Carlos Guijarro verfasserin aut Raquel Campuzano Ruiz verfasserin aut Manuel Rodríguez Piñero verfasserin aut José Francisco Valderrama Marcos verfasserin aut Antonio M. Botana López verfasserin aut Ana Morais López verfasserin aut José Antonio García Donaire verfasserin aut Juan Carlos Obaya verfasserin aut Luis Castilla Guerra verfasserin aut Vicente Pallares Carratalá verfasserin aut Isabel Egocheaga Cabello verfasserin aut Mercedes Salgueira Lazo verfasserin aut María Mar Castellanos Rodrigo verfasserin aut José María Mostaza Prieto verfasserin aut Juan José Gómez Doblas verfasserin aut Antonio Buño Soto verfasserin aut In Nefrología (English Edition) Elsevier, 2017 43(2023), 4, Seite 474-483 (DE-627)837956323 (DE-600)2837917-2 20132514 nnns volume:43 year:2023 number:4 pages:474-483 https://doi.org/10.1016/j.nefroe.2023.08.002 kostenfrei https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 kostenfrei http://www.sciencedirect.com/science/article/pii/S2013251423001335 kostenfrei https://doaj.org/toc/2013-2514 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 43 2023 4 474-483
allfields_unstemmed	10.1016/j.nefroe.2023.08.002 doi (DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41 DE-627 ger DE-627 rakwb eng RC870-923 Teresa Arrobas Velilla verfasserin aut Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio. Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology Carlos Guijarro verfasserin aut Raquel Campuzano Ruiz verfasserin aut Manuel Rodríguez Piñero verfasserin aut José Francisco Valderrama Marcos verfasserin aut Antonio M. Botana López verfasserin aut Ana Morais López verfasserin aut José Antonio García Donaire verfasserin aut Juan Carlos Obaya verfasserin aut Luis Castilla Guerra verfasserin aut Vicente Pallares Carratalá verfasserin aut Isabel Egocheaga Cabello verfasserin aut Mercedes Salgueira Lazo verfasserin aut María Mar Castellanos Rodrigo verfasserin aut José María Mostaza Prieto verfasserin aut Juan José Gómez Doblas verfasserin aut Antonio Buño Soto verfasserin aut In Nefrología (English Edition) Elsevier, 2017 43(2023), 4, Seite 474-483 (DE-627)837956323 (DE-600)2837917-2 20132514 nnns volume:43 year:2023 number:4 pages:474-483 https://doi.org/10.1016/j.nefroe.2023.08.002 kostenfrei https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 kostenfrei http://www.sciencedirect.com/science/article/pii/S2013251423001335 kostenfrei https://doaj.org/toc/2013-2514 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 43 2023 4 474-483
allfieldsGer	10.1016/j.nefroe.2023.08.002 doi (DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41 DE-627 ger DE-627 rakwb eng RC870-923 Teresa Arrobas Velilla verfasserin aut Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio. Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology Carlos Guijarro verfasserin aut Raquel Campuzano Ruiz verfasserin aut Manuel Rodríguez Piñero verfasserin aut José Francisco Valderrama Marcos verfasserin aut Antonio M. Botana López verfasserin aut Ana Morais López verfasserin aut José Antonio García Donaire verfasserin aut Juan Carlos Obaya verfasserin aut Luis Castilla Guerra verfasserin aut Vicente Pallares Carratalá verfasserin aut Isabel Egocheaga Cabello verfasserin aut Mercedes Salgueira Lazo verfasserin aut María Mar Castellanos Rodrigo verfasserin aut José María Mostaza Prieto verfasserin aut Juan José Gómez Doblas verfasserin aut Antonio Buño Soto verfasserin aut In Nefrología (English Edition) Elsevier, 2017 43(2023), 4, Seite 474-483 (DE-627)837956323 (DE-600)2837917-2 20132514 nnns volume:43 year:2023 number:4 pages:474-483 https://doi.org/10.1016/j.nefroe.2023.08.002 kostenfrei https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 kostenfrei http://www.sciencedirect.com/science/article/pii/S2013251423001335 kostenfrei https://doaj.org/toc/2013-2514 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 43 2023 4 474-483
allfieldsSound	10.1016/j.nefroe.2023.08.002 doi (DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41 DE-627 ger DE-627 rakwb eng RC870-923 Teresa Arrobas Velilla verfasserin aut Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio. Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology Carlos Guijarro verfasserin aut Raquel Campuzano Ruiz verfasserin aut Manuel Rodríguez Piñero verfasserin aut José Francisco Valderrama Marcos verfasserin aut Antonio M. Botana López verfasserin aut Ana Morais López verfasserin aut José Antonio García Donaire verfasserin aut Juan Carlos Obaya verfasserin aut Luis Castilla Guerra verfasserin aut Vicente Pallares Carratalá verfasserin aut Isabel Egocheaga Cabello verfasserin aut Mercedes Salgueira Lazo verfasserin aut María Mar Castellanos Rodrigo verfasserin aut José María Mostaza Prieto verfasserin aut Juan José Gómez Doblas verfasserin aut Antonio Buño Soto verfasserin aut In Nefrología (English Edition) Elsevier, 2017 43(2023), 4, Seite 474-483 (DE-627)837956323 (DE-600)2837917-2 20132514 nnns volume:43 year:2023 number:4 pages:474-483 https://doi.org/10.1016/j.nefroe.2023.08.002 kostenfrei https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 kostenfrei http://www.sciencedirect.com/science/article/pii/S2013251423001335 kostenfrei https://doaj.org/toc/2013-2514 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 43 2023 4 474-483
language	English
source	In Nefrología (English Edition) 43(2023), 4, Seite 474-483 volume:43 year:2023 number:4 pages:474-483
sourceStr	In Nefrología (English Edition) 43(2023), 4, Seite 474-483 volume:43 year:2023 number:4 pages:474-483
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos Diseases of the genitourinary system. Urology
isfreeaccess_bool	true
container_title	Nefrología (English Edition)
authorswithroles_txt_mv	Teresa Arrobas Velilla @@aut@@ Carlos Guijarro @@aut@@ Raquel Campuzano Ruiz @@aut@@ Manuel Rodríguez Piñero @@aut@@ José Francisco Valderrama Marcos @@aut@@ Antonio M. Botana López @@aut@@ Ana Morais López @@aut@@ José Antonio García Donaire @@aut@@ Juan Carlos Obaya @@aut@@ Luis Castilla Guerra @@aut@@ Vicente Pallares Carratalá @@aut@@ Isabel Egocheaga Cabello @@aut@@ Mercedes Salgueira Lazo @@aut@@ María Mar Castellanos Rodrigo @@aut@@ José María Mostaza Prieto @@aut@@ Juan José Gómez Doblas @@aut@@ Antonio Buño Soto @@aut@@
publishDateDaySort_date	2023-01-01T00:00:00Z
hierarchy_top_id	837956323
id	DOAJ099607034
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099607034</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414043019.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nefroe.2023.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099607034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJafe49b06e4354350a99f002b8f179c41</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC870-923</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Teresa Arrobas Velilla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Apolipoproteína B</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioquímica</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Colesterol</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Consenso</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enfermedades cardiovasculares</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lípidos</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the genitourinary system. Urology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos Guijarro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Raquel Campuzano Ruiz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Manuel Rodríguez Piñero</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Francisco Valderrama Marcos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Antonio M. Botana López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ana Morais López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Antonio García Donaire</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juan Carlos Obaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luis Castilla Guerra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vicente Pallares Carratalá</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Isabel Egocheaga Cabello</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mercedes Salgueira Lazo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">María Mar Castellanos Rodrigo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José María Mostaza Prieto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juan José Gómez Doblas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Antonio Buño Soto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nefrología (English Edition)</subfield><subfield code="d">Elsevier, 2017</subfield><subfield code="g">43(2023), 4, Seite 474-483</subfield><subfield code="w">(DE-627)837956323</subfield><subfield code="w">(DE-600)2837917-2</subfield><subfield code="x">20132514</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:474-483</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nefroe.2023.08.002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/afe49b06e4354350a99f002b8f179c41</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2013251423001335</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2013-2514</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2023</subfield><subfield code="e">4</subfield><subfield code="h">474-483</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Teresa Arrobas Velilla
spellingShingle	Teresa Arrobas Velilla misc RC870-923 misc Apolipoproteína B misc Bioquímica misc Colesterol misc Consenso misc Enfermedades cardiovasculares misc Lípidos misc Diseases of the genitourinary system. Urology Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
authorStr	Teresa Arrobas Velilla
ppnlink_with_tag_str_mv	@@773@@(DE-627)837956323
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC870-923
illustrated	Not Illustrated
issn	20132514
topic_title	RC870-923 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? Apolipoproteína B Bioquímica Colesterol Consenso Enfermedades cardiovasculares Lípidos
topic	misc RC870-923 misc Apolipoproteína B misc Bioquímica misc Colesterol misc Consenso misc Enfermedades cardiovasculares misc Lípidos misc Diseases of the genitourinary system. Urology
topic_unstemmed	misc RC870-923 misc Apolipoproteína B misc Bioquímica misc Colesterol misc Consenso misc Enfermedades cardiovasculares misc Lípidos misc Diseases of the genitourinary system. Urology
topic_browse	misc RC870-923 misc Apolipoproteína B misc Bioquímica misc Colesterol misc Consenso misc Enfermedades cardiovasculares misc Lípidos misc Diseases of the genitourinary system. Urology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Nefrología (English Edition)
hierarchy_parent_id	837956323
hierarchy_top_title	Nefrología (English Edition)
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)837956323 (DE-600)2837917-2
title	Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
ctrlnum	(DE-627)DOAJ099607034 (DE-599)DOAJafe49b06e4354350a99f002b8f179c41
title_full	Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
author_sort	Teresa Arrobas Velilla
journal	Nefrología (English Edition)
journalStr	Nefrología (English Edition)
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2023
contenttype_str_mv	txt
container_start_page	474
author_browse	Teresa Arrobas Velilla Carlos Guijarro Raquel Campuzano Ruiz Manuel Rodríguez Piñero José Francisco Valderrama Marcos Antonio M. Botana López Ana Morais López José Antonio García Donaire Juan Carlos Obaya Luis Castilla Guerra Vicente Pallares Carratalá Isabel Egocheaga Cabello Mercedes Salgueira Lazo María Mar Castellanos Rodrigo José María Mostaza Prieto Juan José Gómez Doblas Antonio Buño Soto
container_volume	43
class	RC870-923
format_se	Elektronische Aufsätze
author-letter	Teresa Arrobas Velilla
doi_str_mv	10.1016/j.nefroe.2023.08.002
author2-role	verfasserin
title_sort	consensus document for lipid profile determination and reporting in spanish clinical laboratories. what parameters should be included in a basic lipid profile?
callnumber	RC870-923
title_auth	Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
abstract	Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.
abstractGer	Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.
abstract_unstemmed	Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	4
title_short	Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
url	https://doi.org/10.1016/j.nefroe.2023.08.002 https://doaj.org/article/afe49b06e4354350a99f002b8f179c41 http://www.sciencedirect.com/science/article/pii/S2013251423001335 https://doaj.org/toc/2013-2514
remote_bool	true
author2	Carlos Guijarro Raquel Campuzano Ruiz Manuel Rodríguez Piñero José Francisco Valderrama Marcos Antonio M. Botana López Ana Morais López José Antonio García Donaire Juan Carlos Obaya Luis Castilla Guerra Vicente Pallares Carratalá Isabel Egocheaga Cabello Mercedes Salgueira Lazo María Mar Castellanos Rodrigo José María Mostaza Prieto Juan José Gómez Doblas Antonio Buño Soto
author2Str	Carlos Guijarro Raquel Campuzano Ruiz Manuel Rodríguez Piñero José Francisco Valderrama Marcos Antonio M. Botana López Ana Morais López José Antonio García Donaire Juan Carlos Obaya Luis Castilla Guerra Vicente Pallares Carratalá Isabel Egocheaga Cabello Mercedes Salgueira Lazo María Mar Castellanos Rodrigo José María Mostaza Prieto Juan José Gómez Doblas Antonio Buño Soto
ppnlink	837956323
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1016/j.nefroe.2023.08.002
callnumber-a	RC870-923
up_date	2024-07-03T23:34:16.639Z
_version_	1803602788759896064
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099607034</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414043019.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nefroe.2023.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099607034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJafe49b06e4354350a99f002b8f179c41</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC870-923</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Teresa Arrobas Velilla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports. Resumen: Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro pais. El control adecuado de las alteraciones del metabolismo lipidico es un reto clave en prevencion cardiovascular que esta lejos de alcanzarse en la practica clinica real. Existe una gran heterogeneidad en los informes del metabolismo lipidico de los laboratorios clinicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades cientificas implicadas en la atencion de los pacientes de riesgo vascular hemos elaborado este documento con una propuesta basica de consenso sobre la determinacion del perfil lipidico basico en prevencion cardiovascular, recomendaciones para su realizacion y unificacion de criterios para incorporar los objetivos de control lipidico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Apolipoproteína B</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioquímica</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Colesterol</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Consenso</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enfermedades cardiovasculares</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lípidos</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the genitourinary system. Urology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos Guijarro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Raquel Campuzano Ruiz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Manuel Rodríguez Piñero</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Francisco Valderrama Marcos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Antonio M. Botana López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ana Morais López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Antonio García Donaire</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juan Carlos Obaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luis Castilla Guerra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vicente Pallares Carratalá</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Isabel Egocheaga Cabello</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mercedes Salgueira Lazo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">María Mar Castellanos Rodrigo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José María Mostaza Prieto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juan José Gómez Doblas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Antonio Buño Soto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nefrología (English Edition)</subfield><subfield code="d">Elsevier, 2017</subfield><subfield code="g">43(2023), 4, Seite 474-483</subfield><subfield code="w">(DE-627)837956323</subfield><subfield code="w">(DE-600)2837917-2</subfield><subfield code="x">20132514</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:474-483</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nefroe.2023.08.002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/afe49b06e4354350a99f002b8f179c41</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2013251423001335</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2013-2514</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2023</subfield><subfield code="e">4</subfield><subfield code="h">474-483</subfield></datafield></record></collection>
score	7.4021854

Nicht das Richtige dabei?

Schreiben Sie uns!

Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?